StockTwits
09-08-2009, 06:31 AM
$OPXA Opexa Therapeutics reports additional 'favorable data' with Tovaxin for multiple sclerosis (phase 2b)
go to StockTwits...
go to StockTwits...
View Full Version : $OPXA Opexa Therapeutics reports additional 'favorable data' with Tovaxin for multipl